Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Investigating the safety and efficacy of intra-arterial chilled saline following ischemic stroke

FY 2018-19

Summary
Ischemic stroke impacts over 50,000 Canadians each year, costing billions of dollars. Despite recent treatment advances, not all patients benefit. My goal is to benefit all patients - especially those that do not respond to current stroke treatments. To this end, I will evaluate the safety and effectiveness of a novel therapy, known as intra-arterial chilled saline that is hypothesized to work in synergy with current treatment methods. Frankly, animal research findings do not tend to translate to patients. This is often due to unrealistic experimental design. For example, it is not uncommon to see small sample sizes, inappropriate stroke models, and impossibly high treatment dosages used in animal research. These design flaws lead to a paradoxical overestimate of treatment effectiveness in animals, and underwhelming results in patient trials. My research will bridge the gap between treating stroke models, and real strokes. This research has been crafted in collaboration with clinicians that are interested in future use of this method. As such, this data will guide future clinical research and trials. Our approach involves the use of a rat model that mimics our target population, and a more realistic treatment protocol than previous studies, with attention to both risks and potential benefits. I have three aims, which will address the safety and efficacy of the proposed treatment through relevant biological and behavioural endpoints. I hypothesize that intra-arterial chilled saline will improve neurological outcomes, with low risk. Multimodal assessment will confer more confidence in our findings. Although early studies using this therapy in rodents and a few patients are promising, more studies are needed to understand this approach before more humans are tested.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406295
Name
Liddle Lane
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the safety and efficacy of intra-arterial chilled saline following ischemic stroke
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Efficacy; Hemorrhagic Transformation; Intra-Arterial Chilled Saline; Ischemic Stroke; Neuroprotection; Safety; Stroke; Therapeutic Hypothermia; Translation; Translational
Abstract
Ischemic stroke impacts over 50,000 Canadians each year, costing billions of dollars. Despite recent treatment advances, not all patients benefit. My goal is to benefit all patients - especially those that do not respond to current stroke treatments. To this end, I will evaluate the safety and effectiveness of a novel therapy, known as intra-arterial chilled saline that is hypothesized to work in synergy with current treatment methods. Frankly, animal research findings do not tend to translate to patients. This is often due to unrealistic experimental design. For example, it is not uncommon to see small sample sizes, inappropriate stroke models, and impossibly high treatment dosages used in animal research. These design flaws lead to a paradoxical overestimate of treatment effectiveness in animals, and underwhelming results in patient trials. My research will bridge the gap between treating stroke models, and real strokes. This research has been crafted in collaboration with clinicians that are interested in future use of this method. As such, this data will guide future clinical research and trials. Our approach involves the use of a rat model that mimics our target population, and a more realistic treatment protocol than previous studies, with attention to both risks and potential benefits. I have three aims, which will address the safety and efficacy of the proposed treatment through relevant biological and behavioural endpoints. I hypothesize that intra-arterial chilled saline will improve neurological outcomes, with low risk. Multimodal assessment will confer more confidence in our findings. Although early studies using this therapy in rodents and a few patients are promising, more studies are needed to understand this approach before more humans are tested.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Liddle, Lane
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~